Intrinsic Value of S&P & Nasdaq Contact Us

Seer, Inc. SEER NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Seer, Inc. (SEER) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is neutral — 1 Buy, 2 Hold, 1 Sell.

Analysts estimate Earnings Per Share (EPS) of $-1.40 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.39 vs est $-1.40 (beat +0.9%). 2025: actual $-1.28 vs est $-1.31 (beat +2.3%). Analyst accuracy: 98%.

SEER Analyst Ratings

Hold
4
Ratings
1 Buy
2 Hold
1 Sell
Based on 4 analysts giving stock ratings to Seer, Inc. in the past 3 months
Rating breakdown
Buy
1 25%
Hold
2 50%
Sell
1 25%
25%
Buy
1 analysts
50%
Hold
2 analysts
25%
Sell
1 analysts

EPS Estimates — SEER

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$1.39 vs Est –$1.40 ▲ 1.0% off
2025 Actual –$1.28 vs Est –$1.31 ▲ 2.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — SEER

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.014B vs Est $0.014B ▼ 1.2% off
2025 Actual $0.017B vs Est $0.017B ▼ 2.5% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message